In this study, we present significant evidence to reveal that phosphorylated EZH2 is differently located in cytoplasm and nucleus of breast cancer cells in tumor tissue specimen in a site-specific manner, which suggesting pEZH2 is critical for identify invasiveness and metastasis in HER2-positive BC. This evidence concerns the gene ERBB2 and breast cancer.